Akin Tekin

Medicine & Life Sciences

1. Liver Transplantation 100%
2. Transplants 56%
3. Transplantation 49%
4. Pediatrics 25%
5. Liver 25%
6. Tissue Donors 25%
7. Thrombosis 21%
8. Hepatic Artery 20%
9. Transplant Recipients 18%
10. Alemtuzumab 16%
11. Portal Vein 15%
12. End Stage Liver Disease 14%
13. Immunosuppression 13%
14. Graft Survival 12%
15. Kidney Transplantation 11%
16. Biopsy 11%
17. Survival 10%
18. Antibodies 9%
19. Natural Killer Cells 9%
20. Uterus 9%
21. Kidney 9%
22. Citrulline 8%
23. Veins 8%
24. Graft Rejection 8%
25. Liver Failure 7%
26. Hepatitis C 7%
27. Hepatocellular Carcinoma 7%
28. Abdomen 6%
29. Wolcott-Rallison syndrome 6%
30. Therapeutics 6%
31. Paraffin 6%
32. Liver Diseases 6%
33. Superior Mesenteric Artery 6%
34. Acute Liver Failure 6%
35. Portal Hypertension 5%
36. Fibrosis 5%
37. Hepatoblastoma 5%
38. Immunosuppressive Agents 5%
39. Prune Belly Syndrome 5%
40. Mortality 5%
41. Enterobacteriaceae Infections 5%
42. Hepatopulmonary Syndrome 5%
43. Biomarkers 5%
44. Graft vs Host Disease 5%
45. Alveolar echinococcosis 5%
46. Intestines 5%